Imbio PHA (4.0.0) vs AVIEW Lung Nodule CAD
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A is designed for automated measurement of cardiac structures from CTPA scans to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. In contrast, Tool B focuses on assisting radiologists in detecting and analyzing pulmonary nodules, emphysema, and coronary artery calcification on chest CT scans. While both offer AI-powered analysis of chest CTs for cardiopulmonary conditions, their primary diagnostic targets and specific feature sets are distinct.
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if your primary need is rapid, automated assessment of cardiac structures from CT pulmonary angiogram (CTPA) scans. This tool is ideal for aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension by precisely measuring right ventricular dilation and other key cardiac ratios.
View Imbio PHA (4.0.0) →Choose AVIEW Lung Nodule CAD if…
Choose AVIEW Lung Nodule CAD if you require comprehensive AI-powered assistance for detecting and analyzing pulmonary nodules on chest CT scans, particularly for lung cancer screening and follow-up. This tool is also well-suited for simultaneous quantitative analysis of emphysema and coronary artery calcification, providing a holistic view of lung and cardiac health.
View AVIEW Lung Nodule CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | AVIEW Lung Nodule CAD |
|---|---|---|
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | On-premises and cloud environment |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | AVIEW Lung Nodule CAD |
|---|---|---|
| Name | Imbio PHA (4.0.0) | AVIEW Lung Nodule CAD |
| Company | Imbio | Coreline Soft Co. |
| Primary Clinical Focus | Assesses potential right ventricular dilation and aids in diagnosis and risk stratification of pulmonary embolism and hypertension from CTPA scans. | Assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, and offers comprehensive screening for lung cancer, COPD, and coronary artery calcification. |
| Key Measurements/Analyses | Automated measurement of right and left ventricle diameters, main pulmonary artery and aorta diameters; calculates RV/LV and PA/Ao ratios. | AI-based pulmonary nodule detection (3-20 mm), nodule classification, 3D nodule size and volume quantification, nodule matching and volume doubling time (VDT) calculation, quantitative emphysema analysis, coronary artery calcification (CAC) scoring. |
| Report Generation | Provides summary reports in PDF format. | Automatic report generation based on Lung-RADS classification. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Oncology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and AVIEW Lung Nodule CAD.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Imbio PHA (Tool A) is designed to automatically measure cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension. AVIEW Lung Nodule CAD (Tool B) assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, offering comprehensive screening for lung cancer, COPD, and coronary artery calcification.
Imbio PHA (Tool A) specifically utilizes CT pulmonary angiogram (CTPA) scans for its analysis. AVIEW Lung Nodule CAD (Tool B) analyzes chest CT scans.
Imbio PHA (Tool A) provides automated measurements of right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios, generating annotated DICOM images and PDF summary reports. AVIEW Lung Nodule CAD (Tool B) offers AI-based pulmonary nodule detection (3-20 mm), nodule classification (solid, part-solid, non-solid), 3D nodule size and volume quantification, automatic report generation based on Lung-RADS classification, nodule matching and volume doubling time (VDT) calculation, quantitative emphysema analysis (e.g., Low Attenuation Area - LAA, emphysema index), and coronary artery calcification (CAC) scoring (Agatston, volume, mass scores).
Imbio PHA (Tool A) integrates with native DICOM tools and workflows, sending annotated DICOM images and PDF summary reports directly into the patient study in PACS. AVIEW Lung Nodule CAD (Tool B) complies with DICOM standards, allowing it to be linked with Picture Archiving and Communication Systems (PACS) and provides a separate user interface for analysis, identification, storage, and transmission of quantified values related to lung nodules.